Semaglutide: Dosage and Administration Semaglutide is available in injectable form and is typically prescribed for the treatment of type 2 diabetes
Beyond dermatology, GHK-Cu is gaining traction in neurology and respiratory health, where its ability to cross biological barriers and influence gene expression opens new therapeutic avenues
UTIs are common in the general population, especially among women, and coincidental timing with tirzepatide use can create a false association
By activating GLP-1 receptors, retatrutide promotes insulin secretion, suppresses glucagon release, and reduces appetite
2015;308:E6419
Originally developed by Novo Nordisk in the late 1990s, ipamorelin represents one of the most selective growth hormone-releasing peptides (GHRPs) available, demonstrating minimal activation of secondary hormone pathways compared to other compounds in its class